Shuttle Pharmaceuticals Holdings, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| SHPH | -24.13% | -43.37% | -70.83% | -87.86% |
| XLV | +2.97% | -4.83% | -3.44% | +12.62% |
| Alpha (stock − sector) | -27.10% | -38.54% | -67.39% | -100.48% |